UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.456

Sortiert nach

Principles of Inorganic Materials Design (3rd Edition)

3rd edition., 2020

Volltextzugriff (PDF)

Clinical value of echocardiographic tissue characterization in the diagnosis of myocarditis

European heart journal, 1996-01, Vol.17 (1), p.135-142

1996

Volltextzugriff (PDF)

Sorption Efficiency of a New Sorbent towards Cadmium(II): Methylphosphonic Acid Grafted Polystyrene Resin

Journal of chemistry, 2013-01, Vol.2013 (1)

2013

Volltextzugriff (PDF)

Cognitive Remediation Interventions for Gambling Disorder: A Systematic Review

Frontiers in psychology, 2017-12, Vol.8, p.1961-1961

2017

Volltextzugriff (PDF)

Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases

Nucleic acids research, 2012-01, Vol.40 (Database issue), p.D992

2012

Volltextzugriff (PDF)

BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk

Journal of medical genetics, 2012-08, Vol.49 (8), p.525-532

2012

Volltextzugriff (PDF)

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers

Human molecular genetics, 2009-11, Vol.18 (22), p.4442-4456

2009

Volltextzugriff (PDF)

Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer

PLoS genetics, 2010-10, Vol.6 (10), p.e1001183-e1001183

2010

Volltextzugriff (PDF)

Assessing care models implemented in primary healthcare for persons with dementia: a mixed-methods study protocol

BMJ open, 2020-05, Vol.10 (5), p.e035916-e035916

2020

Volltextzugriff (PDF)

Directives anticipées : influence de la qualité de vie sur les choix thérapeutiques

La revue de medecine interne, 2016-12, Vol.37, p.A106-A106

2016

Volltextzugriff (PDF)

Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers

Human molecular genetics, 2010-07, Vol.19 (14), p.2886-2897

2010

Volltextzugriff (PDF)

Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3

The European respiratory journal, 2012-01, Vol.39 (1), p.172-179

2012

Volltextzugriff (PDF)

Genetic Variation at 9p22.2 and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers

JNCI : Journal of the National Cancer Institute, 2011-01, Vol.103 (2), p.105-116

2011

Volltextzugriff (PDF)

The rs2910164:G>C SNP in the MIR146A gene is not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

Human mutation, 2011-09, Vol.32 (9), p.1004-1007

2011

Volltextzugriff (PDF)

Common Genetic Variation at BARD1 Is Not Associated with Breast Cancer Risk in BRCA1 or BRCA2 Mutation Carriers

Cancer epidemiology, biomarkers & prevention, 2011, Vol.20 (5), p.1032-1038

2011

Volltextzugriff (PDF)

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)

British journal of cancer, 2009, Vol.101 (12), p.2048-2054

2009

Volltextzugriff (PDF)

A new scoring system for the diagnosis of BRCA1/2 associated breast-ovarian cancer predisposition

Bulletin du cancer, 2011-07, Vol.98 (7), p.779-95

2011

Volltextzugriff (PDF)